introduction
A world-renowned pharmaceutical company in the United States settled in Shanghai to carry out pharmaceutical research and development, but according to relevant reports, the American pharmaceutical company not only did everything possible to get the genes of Chinese, but also recruited Chinese for drug trial research, and their drugs are specifically for Chinese use and will not be exported to other regions.
Such news makes people have to wonder, what is the real purpose of this American pharmaceutical company's entry into China?
Moderna Medical, Inc., USA
Founded in 2010, Moderna Medical has been committed to mRNA technology since its founder, Derek Rossi, a stem cell biologist, who discovered a way to edit mRNA by transfecting it into human cells and then transforming it into stem cells to further differentiate into a target cell type.
mRNA is simply a class of single-stranded ribonucleic acid based on human genes that can carry genetic information to guide protein synthesis, that is to say, this is the study of human genetic DNA.
With this research result, Derek Rossi founded Moderna Medical based on this research, and the company's research direction is also mRNA drug production, and then Moderna Medical also cooperated with AstraZeneca to jointly develop and commercialize mRNA, which is to put it bluntly, to make money with this research.
As a result of the collaboration, they have worked together to apply mRNA technology to the treatment of cardiovascular diseases, chronic diseases such as metabolism and kidneys, as well as specific cancers.
Because mRNA is an important discovery of human gene cells, and it is still a relatively advanced research discovery, there are many people who want to cooperate with Moderna, and in 2014, Moderna ushered in its own important partner and began to conduct research in the field of rare diseases.
In just one year, Moderna has developed a vaccine against influenza, which is an mRNA vaccine for avian influenza applied to humans, which is the first in history, and as the company has expanded step by step, the company's research laboratories have become larger and larger, and more and more research projects have been studied.
But at this time, Moderna was also a normal medical company, until the outbreak of the global epidemic, Moderna made a lot of money during the epidemic.
At that time, the new crown virus swept the world, and everyone began to research a vaccine against the new coronavirus, and Moderna Medical, which was already quite large at that time, of course, would not let go of this opportunity.
With the approval of the U.S. Food and Drug Administration, Moderna's vaccine against the new coronavirus entered clinical trials, and in the same year, Moderna's vaccine was put into use in the United States, and it is also recommended that Americans over 18 years old be vaccinated.
At the same time, Moderna began to further research new vaccines related to it, and later developed three new vaccines for influenza and respiration, and then established subsidiaries in Japan, South Korea and other places.
The purpose of Moderna to set up subsidiaries in other countries is self-evident, it is also to better sell the vaccines developed by itself and make further money, and during this period, Moderna has proposed to sell vaccines about the new crown virus in China, trying to open the Chinese market through this means, but Moderna did not expect that the mainland had a tough attitude and asked for "technology for market", but Moderna did not agree, so it could only give up the Chinese market.
In 2020 and 2021, Moderna's stock price once rose to $500, with a market value estimated to exceed $100 billion.
However, as soon as the coronavirus subsided and the World Health Organization announced that the new crown epidemic was no longer an international concern, Moderna was devastated, with the stock falling by more than $400 and its market value evaporating by nearly half compared to its peak.
In the face of such losses, Moderna needed to find a new way out, so it turned its mind to China, but Moderna has never given up on opening up the Chinese market, after all, China has a population of more than one billion people, and it is a group that cannot be ignored in the world.
However, this time Moderna's intentions are not so bright, and the reason for choosing to settle in Shanghai is even more alarming.
Fudan University in Shanghai publishes Chinese genes
Since 2021, a number of scientific research institutions have begun to devote themselves to studying the genetic information of Chinese, in order to study accurately, the research team traveled to many places, found people of different nationalities and different regions to extract blood samples, collected these blood, and began to conduct research, they want to know what kind of genetic differences in people across the country.
After continuous research and analysis, the researchers studied the genome map of the mainland, which contains 34,000 genetic structural variations, as well as more than 1,000 protein-coding genes and 5 million base pairs, which are really secrets hidden deep in the DNA of Chinese.
And this DNA gene contains all kinds of secrets of the Chinese, as well as biological characteristics, although this is conducive to better solving the human disease and development, but this is released, and the secrets of the Chinese are made public.
However, after the study was clear, the genetic map of Chinese appeared in the journal Nature, and together with the genetic map, Fudan University studied about the unique genetic variation of Chinese.
After this news was announced, it caused an uproar, and the hidden dangers brought about by such a bold disclosure of the genetic map to the public are endless, and it is very likely that other countries will create hidden dangers for the mainland based on such a genetic map.
At the same time, this also violates the regulations of the Ministry of Science and Technology of the mainland, which stipulates that human genetic resources from the mainland cannot be provided abroad, but this gene map is obviously to make the genetic secrets of Chinese people public, but this regulation takes effect after the release of the gene map.
Physical injuries may not be fatal, but genetic diseases are basically fatal, and may carry the risk of extinction, although the United Nations has relevant regulations on this, prohibiting the use of biological weapons, but the United States withdrew in 2001.
And the Americans have exposed the secret of their research on human genes to make biological and chemical weapons in "Gene War", and the United States has also secretly built many biological laboratories around the world, and this time the United States has set its sights on China.
Moderna opens in Shanghai
In July 2023, Moderna of the United States will settle in Shanghai and begin to research, develop, produce and sell provincial medicine, and the scale of Moderna's investment in Shanghai is not small, of which industrial land accounts for nearly 270 acres and an investment of more than 3 billion.
And according to relevant reports, the research of Moderna company in Shanghai is specifically aimed at the needs of the Chinese market, and it is called for the benefit of the public, in just three months, the company has completed all the work, realized the factory settlement in Shanghai, and began to carry out production research.
This has to make people doubt the purpose of Moderna Company, after all, Moderna Company decided to settle in Shanghai, that is, after the Chinese genetic map was published, and completed the settlement and production in just 3 months, such a time makes people feel too fast, is this not planned.
And Moderna, as we mentioned earlier, started with genetic research, which has to make people more suspicious of the company's purpose and intentions.
And this company also proposed that when conducting research, it is all research for Chinese, and the drugs produced are only sold to Chinese, not sold to the outside world, which makes people even more suspicious, on the surface it seems to be beneficial to the Chinese, but really dare not think about it, a foreign company for profit, does not seek profit to sell to Chinese, or American companies, is this reasonable?
And this company is also a gene research company, I'm afraid it doesn't want to develop genetic drugs for Chinese, right?
Of course, this is not groundless, and a spokesman for Moderna did not just say it himself: "Any drugs produced under this agreement will only be for the use of the Chinese people and will not be exported." "That's the case.
The American company also announced relevant recruitment news on the company's relevant social platforms, and the news pointed out that pure Chinese should be recruited for drug trials.
This news makes people very puzzled, why does an American company need pure China to conduct drug trials, and what does it need to be pure Chinese, is this sure that it is not a genetic experiment for Chinese? Is such a drug definitely not a genetic drug for Chinese?
One thing is a coincidence, and if you want to say that it is a coincidence, it is too deliberate! Is the purpose of this US company really to simply study pharmaceuticals? This makes people wonder.
epilogue
Setting up a pharmaceutical factory in China, and the timing is so coincidental, and also recruiting pure Chinese for drug testing, or a company specializing in genetics, this is really difficult to think about!
Resources:
Guangming.com - The Ministry of Science and Technology intends to stipulate that human genetic resources from the mainland shall not be provided abroad
China's strategic emerging industry, Moderna, has made its first huge investment in China to produce vaccines for Chinese use only
Strait Time and Space - Specially developed drugs for Chinese? The real purpose of the US military's cooperative pharmaceutical companies entering China is worth vigilance
Sina Finance - Moderna's first signing in China! The medicines produced will be used only by Chinese"